These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 22405836)

  • 1. Vicious cycle in liver carcinogenesis: an epigenetic mirage.
    Bioulac-Sage P; Balabaud C; Chevet E
    Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):200-1. PubMed ID: 22405836
    [No Abstract]   [Full Text] [Related]  

  • 2. An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis.
    Hatziapostolou M; Polytarchou C; Aggelidou E; Drakaki A; Poultsides GA; Jaeger SA; Ogata H; Karin M; Struhl K; Hadzopoulou-Cladaras M; Iliopoulos D
    Cell; 2011 Dec; 147(6):1233-47. PubMed ID: 22153071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing a cancer cell in the inflammatory tissue: an epigenetic circuit.
    Mu W; Hui L
    Acta Biochim Biophys Sin (Shanghai); 2012 Apr; 44(4):279-80. PubMed ID: 22467139
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma.
    Beyazit Y; Kekilli M; Kurt M; Sayilir A; Tas A; Onal IK
    Aliment Pharmacol Ther; 2010 Jul; 32(2):304-5. PubMed ID: 20636625
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatocyte nuclear factor 4 (HNF4) in epithelial development and carcinogenesis].
    Lazarevich NL; Al'pern DV
    Mol Biol (Mosk); 2008; 42(5):786-97. PubMed ID: 18988528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs control hepatocarcinogenesis by regulating hepatocyte nuclear factor 4α-inflammatory signal feedback loops.
    Wang H; Gao B
    Hepatology; 2014 Nov; 60(5):1466-8. PubMed ID: 24996014
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNA-feedback loop as a key modulator of liver tumorigenesis and inflammation.
    Gougelet A; Colnot S
    World J Gastroenterol; 2013 Jan; 19(4):440-4. PubMed ID: 23382622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.
    Won C; Lee CS; Lee JK; Kim TJ; Lee KH; Yang YM; Kim YN; Ye SK; Chung MH
    Anticancer Res; 2010 Feb; 30(2):481-8. PubMed ID: 20332458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of glypican-3 in human hepatocellular carcinoma.
    Suzuki M; Sugimoto K; Tanaka J; Tameda M; Inagaki Y; Kusagawa S; Nojiri K; Beppu T; Yoneda K; Yamamoto N; Ito M; Yoneda M; Uchida K; Takase K; Shiraki K
    Anticancer Res; 2010 Dec; 30(12):5055-61. PubMed ID: 21187490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway.
    Brock M; Trenkmann M; Gay RE; Michel BA; Gay S; Fischler M; Ulrich S; Speich R; Huber LC
    Circ Res; 2009 May; 104(10):1184-91. PubMed ID: 19390056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
    Ning BF; Ding J; Yin C; Zhong W; Wu K; Zeng X; Yang W; Chen YX; Zhang JP; Zhang X; Wang HY; Xie WF
    Cancer Res; 2010 Oct; 70(19):7640-51. PubMed ID: 20876809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and signaling, complex interaction by feedback loops.
    Völler D; Bosserhoff A
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):128-30. PubMed ID: 22409367
    [No Abstract]   [Full Text] [Related]  

  • 13. [The inhibitory effect of RNA interference on STAT3 expression in liver cancer cell line SMMC7721].
    Liao WJ; Mei MH; Qin LL; Chen Q; Yuan SG; Liu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):615-7. PubMed ID: 21651859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells.
    Liu Y; Liu A; Xu Z; Yu W; Wang H; Li C; Lin J
    Apoptosis; 2011 May; 16(5):502-10. PubMed ID: 21311975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.
    Xu L; Hui L; Wang S; Gong J; Jin Y; Wang Y; Ji Y; Wu X; Han Z; Hu G
    Cancer Res; 2001 Apr; 61(7):3176-81. PubMed ID: 11306505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
    Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of genetic and epigenetic alterations in hepatocarcinogenesis.
    Herath NI; Leggett BA; MacDonald GA
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):15-21. PubMed ID: 16706806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reprogramming factors of human somatic cells are novel targets for human hepatocellular carcinoma therapy.
    Moriguchi H
    Hepatology; 2009 Dec; 50(6):2046; author reply 2046-7. PubMed ID: 19937684
    [No Abstract]   [Full Text] [Related]  

  • 19. Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma.
    Yang SF; Wang SN; Wu CF; Yeh YT; Chai CY; Chunag SC; Sheen MC; Lee KT
    J Clin Pathol; 2007 Jun; 60(6):642-8. PubMed ID: 16901975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioautographic study on RNA labeling in rat liver parenchyma during DAB carcinogenesis.
    Daoust R; Simard A
    Cancer Res; 1968 May; 28(5):874-80. PubMed ID: 4297346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.